Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Authorization Safety Study of iv Ibandronate (Bonviva) in Postmenopausal Osteoporosis, Observational, Non-interventional Open Label Trial

NCT02271204 is registered in ClinicalTrials.gov with Clinic of Endocrinology and Metabolic Disorders, Macedonia as lead sponsor.

NCT NCT02271204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Authorization Safety Study of iv Ibandronate (Bonviva) in Postmenopausal Osteoporosis, Observational, Non-interventional Open Label Trial
Lead sponsor
Clinic of Endocrinology and Metabolic Disorders, Macedonia
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
April 30, 2014
Enrollment
700 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis